STK11 and cancer: GSEA enrichment analysis (Figure 5) showed that the STK11 mutations were associated with multiple cancer-related pathways, including oxidative phosphorylation, unfolded protein response, peroxisome, protein secretion, Wnt/beta catenin signaling and PI3K/AKT/mTOR signaling.